Home > > > Report Detail

Global Digital Companion Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 21-Sep-2022
No. of pages: 107
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Digital Companion Diagnostics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Digital Companion Diagnostics market. Further, it explains the major drivers and regional dynamics of the global Digital Companion Diagnostics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Roche Holdings (Switzerland)

- Abbott Laboratories (US)

- Thermo Fisher Scientific (US)

- Agilent Technologies (US)

- Life Technologies (US)

- GE Healthcare (UK)

- Agendia (Angola)

- Qiagen (Germany)

- Genomic Health (US)

- Myriad Genetics (US)

- Advanced Cell Diagnostics (US)

- Danaher (US)

- Applied Proteomics (US)

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Digital Companion Diagnostics Segment by Type

- Polymerase Chain Reaction (PCR)

- Immunohistochemistry (IHC)

- In Situ Hybridization (ISH)

- Next Generation Sequencing (NGS)

Digital Companion Diagnostics Segment by Application

- Hospitals

- Pharmaceutical Companies

- Laboratories

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Digital Companion Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Digital Companion Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Digital Companion Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Digital Companion Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Companion Diagnostics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Digital Companion Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Digital Companion Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche Holdings (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Life Technologies (US), GE Healthcare (UK), Agendia (Angola), Qiagen (Germany) and Genomic Health (US), etc.

Global Digital Companion Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Digital Companion Diagnostics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Digital Companion Diagnostics Market Size (2017-2028)
2.2 Digital Companion Diagnostics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Digital Companion Diagnostics Market Size by Region (2017-2022)
2.4 Global Digital Companion Diagnostics Market Size Forecast by Region (2023-2028)
2.5 Global Top Digital Companion Diagnostics Countries Ranking by Market Size
3 Digital Companion Diagnostics Competitive by Company
3.1 Global Digital Companion Diagnostics Revenue by Players
3.1.1 Global Digital Companion Diagnostics Revenue by Players (2017-2022)
3.1.2 Global Digital Companion Diagnostics Market Share by Players (2017-2022)
3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Digital Companion Diagnostics Revenue
3.4 Global Digital Companion Diagnostics Market Concentration Ratio
3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2021
3.5 Global Digital Companion Diagnostics Key Players Head office and Area Served
3.6 Key Players Digital Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Digital Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Digital Companion Diagnostics Breakdown Data by Type
4.1 Global Digital Companion Diagnostics Historic Revenue by Type (2017-2022)
4.2 Global Digital Companion Diagnostics Forecasted Revenue by Type (2023-2028)
5 Global Digital Companion Diagnostics Breakdown Data by Application
5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Digital Companion Diagnostics Revenue by Company (2020-2022)
6.2 North America Digital Companion Diagnostics Revenue by Type (2017-2028)
6.3 North America Digital Companion Diagnostics Revenue by Application (2017-2028)
6.4 North America Digital Companion Diagnostics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Digital Companion Diagnostics Revenue by Company (2020-2022)
7.2 Europe Digital Companion Diagnostics Revenue by Type (2017-2028)
7.3 Europe Digital Companion Diagnostics Revenue by Application (2017-2028)
7.4 Europe Digital Companion Diagnostics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Digital Companion Diagnostics Revenue by Company (2020-2022)
8.2 Asia Pacific Digital Companion Diagnostics Revenue by Type (2017-2028)
8.3 Asia Pacific Digital Companion Diagnostics Revenue by Application (2017-2028)
8.4 Asia Pacific Digital Companion Diagnostics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Digital Companion Diagnostics Revenue by Company (2020-2022)
9.2 Latin America Digital Companion Diagnostics Revenue by Type (2017-2028)
9.3 Latin America Digital Companion Diagnostics Revenue by Application (2017-2028)
9.4 Latin America Digital Companion Diagnostics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Digital Companion Diagnostics Revenue by Company (2020-2022)
10.2 Middle East and Africa Digital Companion Diagnostics Revenue by Type (2017-2028)
10.3 Middle East and Africa Digital Companion Diagnostics Revenue by Application (2017-2028)
10.4 Middle East and Africa Digital Companion Diagnostics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Roche Holdings (Switzerland)
11.1.1 Roche Holdings (Switzerland) Company Details
11.1.2 Roche Holdings (Switzerland) Business Overview
11.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Products and Services
11.1.4 Roche Holdings (Switzerland) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.1.5 Roche Holdings (Switzerland) Digital Companion Diagnostics SWOT Analysis
11.1.6 Roche Holdings (Switzerland) Recent Developments
11.2 Abbott Laboratories (US)
11.2.1 Abbott Laboratories (US) Company Details
11.2.2 Abbott Laboratories (US) Business Overview
11.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Products and Services
11.2.4 Abbott Laboratories (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.2.5 Abbott Laboratories (US) Digital Companion Diagnostics SWOT Analysis
11.2.6 Abbott Laboratories (US) Recent Developments
11.3 Thermo Fisher Scientific (US)
11.3.1 Thermo Fisher Scientific (US) Company Details
11.3.2 Thermo Fisher Scientific (US) Business Overview
11.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Products and Services
11.3.4 Thermo Fisher Scientific (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.3.5 Thermo Fisher Scientific (US) Digital Companion Diagnostics SWOT Analysis
11.3.6 Thermo Fisher Scientific (US) Recent Developments
11.4 Agilent Technologies (US)
11.4.1 Agilent Technologies (US) Company Details
11.4.2 Agilent Technologies (US) Business Overview
11.4.3 Agilent Technologies (US) Digital Companion Diagnostics Products and Services
11.4.4 Agilent Technologies (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.4.5 Agilent Technologies (US) Digital Companion Diagnostics SWOT Analysis
11.4.6 Agilent Technologies (US) Recent Developments
11.5 Life Technologies (US)
11.5.1 Life Technologies (US) Company Details
11.5.2 Life Technologies (US) Business Overview
11.5.3 Life Technologies (US) Digital Companion Diagnostics Products and Services
11.5.4 Life Technologies (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.5.5 Life Technologies (US) Digital Companion Diagnostics SWOT Analysis
11.5.6 Life Technologies (US) Recent Developments
11.6 GE Healthcare (UK)
11.6.1 GE Healthcare (UK) Company Details
11.6.2 GE Healthcare (UK) Business Overview
11.6.3 GE Healthcare (UK) Digital Companion Diagnostics Products and Services
11.6.4 GE Healthcare (UK) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.6.5 GE Healthcare (UK) Digital Companion Diagnostics SWOT Analysis
11.6.6 GE Healthcare (UK) Recent Developments
11.7 Agendia (Angola)
11.7.1 Agendia (Angola) Company Details
11.7.2 Agendia (Angola) Business Overview
11.7.3 Agendia (Angola) Digital Companion Diagnostics Products and Services
11.7.4 Agendia (Angola) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.7.5 Agendia (Angola) Digital Companion Diagnostics SWOT Analysis
11.7.6 Agendia (Angola) Recent Developments
11.8 Qiagen (Germany)
11.8.1 Qiagen (Germany) Company Details
11.8.2 Qiagen (Germany) Business Overview
11.8.3 Qiagen (Germany) Digital Companion Diagnostics Products and Services
11.8.4 Qiagen (Germany) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.8.5 Qiagen (Germany) Digital Companion Diagnostics SWOT Analysis
11.8.6 Qiagen (Germany) Recent Developments
11.9 Genomic Health (US)
11.9.1 Genomic Health (US) Company Details
11.9.2 Genomic Health (US) Business Overview
11.9.3 Genomic Health (US) Digital Companion Diagnostics Products and Services
11.9.4 Genomic Health (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.9.5 Genomic Health (US) Digital Companion Diagnostics SWOT Analysis
11.9.6 Genomic Health (US) Recent Developments
11.10 Myriad Genetics (US)
11.10.1 Myriad Genetics (US) Company Details
11.10.2 Myriad Genetics (US) Business Overview
11.10.3 Myriad Genetics (US) Digital Companion Diagnostics Products and Services
11.10.4 Myriad Genetics (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.10.5 Myriad Genetics (US) Digital Companion Diagnostics SWOT Analysis
11.10.6 Myriad Genetics (US) Recent Developments
11.11 Advanced Cell Diagnostics (US)
11.11.1 Advanced Cell Diagnostics (US) Company Details
11.11.2 Advanced Cell Diagnostics (US) Business Overview
11.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Products and Services
11.11.4 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.11.5 Advanced Cell Diagnostics (US) Recent Developments
11.12 Danaher (US)
11.12.1 Danaher (US) Company Details
11.12.2 Danaher (US) Business Overview
11.12.3 Danaher (US) Digital Companion Diagnostics Products and Services
11.12.4 Danaher (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.12.5 Danaher (US) Recent Developments
11.13 Applied Proteomics (US)
11.13.1 Applied Proteomics (US) Company Details
11.13.2 Applied Proteomics (US) Business Overview
11.13.3 Applied Proteomics (US) Digital Companion Diagnostics Products and Services
11.13.4 Applied Proteomics (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022)
11.13.5 Applied Proteomics (US) Recent Developments
12 Digital Companion Diagnostics Market Dynamics
12.1 Digital Companion Diagnostics Market Trends
12.2 Digital Companion Diagnostics Market Drivers
12.3 Digital Companion Diagnostics Market Challenges
12.4 Digital Companion Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of In Situ Hybridization (ISH)
Table 5. Key Players of Next Generation Sequencing (NGS)
Table 6. Global Digital Companion Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Digital Companion Diagnostics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Digital Companion Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Digital Companion Diagnostics Revenue Market Share by Region (2017-2022)
Table 10. Global Digital Companion Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Digital Companion Diagnostics Market Share by Players (2017-2022)
Table 12. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2021)
Table 13. Ranking of Global Top Digital Companion Diagnostics Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Digital Companion Diagnostics Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Digital Companion Diagnostics Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Digital Companion Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Digital Companion Diagnostics Revenue Market Share by Type (2017-2022)
Table 21. Global Digital Companion Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Digital Companion Diagnostics Revenue Market Share by Type (2023-2028)
Table 23. Global Digital Companion Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Digital Companion Diagnostics Revenue Market Share by Application (2017-2022)
Table 25. Global Digital Companion Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Digital Companion Diagnostics Revenue Market Share by Application (2023-2028)
Table 27. North America Digital Companion Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Digital Companion Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Digital Companion Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Digital Companion Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Digital Companion Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Digital Companion Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Digital Companion Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Digital Companion Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Digital Companion Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Digital Companion Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Digital Companion Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Digital Companion Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Digital Companion Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Digital Companion Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Digital Companion Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Digital Companion Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Digital Companion Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Digital Companion Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Digital Companion Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Digital Companion Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Digital Companion Diagnostics Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Digital Companion Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Digital Companion Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Digital Companion Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Digital Companion Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Digital Companion Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Digital Companion Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Digital Companion Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Digital Companion Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Digital Companion Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Digital Companion Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Digital Companion Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Digital Companion Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Digital Companion Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Digital Companion Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 62. Roche Holdings (Switzerland) Company Details
Table 63. Roche Holdings (Switzerland) Business Overview
Table 64. Roche Holdings (Switzerland) Digital Companion Diagnostics Product and Services
Table 65. Roche Holdings (Switzerland) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 66. Roche Holdings (Switzerland) Digital Companion Diagnostics SWOT Analysis
Table 67. Roche Holdings (Switzerland) Recent Developments
Table 68. Abbott Laboratories (US) Company Details
Table 69. Abbott Laboratories (US) Business Overview
Table 70. Abbott Laboratories (US) Digital Companion Diagnostics Product and Services
Table 71. Abbott Laboratories (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 72. Abbott Laboratories (US) Digital Companion Diagnostics SWOT Analysis
Table 73. Abbott Laboratories (US) Recent Developments
Table 74. Thermo Fisher Scientific (US) Company Details
Table 75. Thermo Fisher Scientific (US) Business Overview
Table 76. Thermo Fisher Scientific (US) Digital Companion Diagnostics Product and Services
Table 77. Thermo Fisher Scientific (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 78. Thermo Fisher Scientific (US) Digital Companion Diagnostics SWOT Analysis
Table 79. Thermo Fisher Scientific (US) Recent Developments
Table 80. Agilent Technologies (US) Company Details
Table 81. Agilent Technologies (US) Business Overview
Table 82. Agilent Technologies (US) Digital Companion Diagnostics Product and Services
Table 83. Agilent Technologies (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 84. Agilent Technologies (US) Digital Companion Diagnostics SWOT Analysis
Table 85. Agilent Technologies (US) Recent Developments
Table 86. Life Technologies (US) Company Details
Table 87. Life Technologies (US) Business Overview
Table 88. Life Technologies (US) Digital Companion Diagnostics Product and Services
Table 89. Life Technologies (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 90. Life Technologies (US) Digital Companion Diagnostics SWOT Analysis
Table 91. Life Technologies (US) Recent Developments
Table 92. GE Healthcare (UK) Company Details
Table 93. GE Healthcare (UK) Business Overview
Table 94. GE Healthcare (UK) Digital Companion Diagnostics Product and Services
Table 95. GE Healthcare (UK) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 96. GE Healthcare (UK) Digital Companion Diagnostics SWOT Analysis
Table 97. GE Healthcare (UK) Recent Developments
Table 98. Agendia (Angola) Company Details
Table 99. Agendia (Angola) Business Overview
Table 100. Agendia (Angola) Digital Companion Diagnostics Product and Services
Table 101. Agendia (Angola) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 102. Agendia (Angola) Digital Companion Diagnostics SWOT Analysis
Table 103. Agendia (Angola) Recent Developments
Table 104. Qiagen (Germany) Company Details
Table 105. Qiagen (Germany) Business Overview
Table 106. Qiagen (Germany) Digital Companion Diagnostics Product and Services
Table 107. Qiagen (Germany) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 108. Qiagen (Germany) Digital Companion Diagnostics SWOT Analysis
Table 109. Qiagen (Germany) Recent Developments
Table 110. Genomic Health (US) Company Details
Table 111. Genomic Health (US) Business Overview
Table 112. Genomic Health (US) Digital Companion Diagnostics Product and Services
Table 113. Genomic Health (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 114. Genomic Health (US) Digital Companion Diagnostics SWOT Analysis
Table 115. Genomic Health (US) Recent Developments
Table 116. Myriad Genetics (US) Company Details
Table 117. Myriad Genetics (US) Business Overview
Table 118. Myriad Genetics (US) Digital Companion Diagnostics Product and Services
Table 119. Myriad Genetics (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 120. Myriad Genetics (US) Digital Companion Diagnostics SWOT Analysis
Table 121. Myriad Genetics (US) Recent Developments
Table 122. Advanced Cell Diagnostics (US) Company Details
Table 123. Advanced Cell Diagnostics (US) Business Overview
Table 124. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product and Services
Table 125. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 126. Advanced Cell Diagnostics (US) Recent Developments
Table 127. Danaher (US) Company Details
Table 128. Danaher (US) Business Overview
Table 129. Danaher (US) Digital Companion Diagnostics Product and Services
Table 130. Danaher (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 131. Danaher (US) Recent Developments
Table 132. Applied Proteomics (US) Company Details
Table 133. Applied Proteomics (US) Business Overview
Table 134. Applied Proteomics (US) Digital Companion Diagnostics Product and Services
Table 135. Applied Proteomics (US) Digital Companion Diagnostics Revenue in Digital Companion Diagnostics Business (2017-2022) & (US$ Million)
Table 136. Applied Proteomics (US) Recent Developments
Table 137. Digital Companion Diagnostics Market Trends
Table 138. Digital Companion Diagnostics Market Drivers
Table 139. Digital Companion Diagnostics Market Challenges
Table 140. Digital Companion Diagnostics Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Digital Companion Diagnostics Sales Market Share by Type: 2021 VS 2028
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Digital Companion Diagnostics Sales Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Digital Companion Diagnostics Report Years Considered
Figure 12. Global Digital Companion Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Digital Companion Diagnostics Market Size 2017-2028 (US$ Million)
Figure 14. Global Digital Companion Diagnostics Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Digital Companion Diagnostics Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Digital Companion Diagnostics Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Digital Companion Diagnostics Market Share by Players in 2021
Figure 18. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2021
Figure 20. North America Digital Companion Diagnostics Revenue Market Share by Company in 2021
Figure 21. North America Digital Companion Diagnostics Revenue Market Share by Type (2017-2028)
Figure 22. North America Digital Companion Diagnostics Revenue Market Share by Application (2017-2028)
Figure 23. North America Digital Companion Diagnostics Revenue Share by Country (2017-2028)
Figure 24. U.S. Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Digital Companion Diagnostics Revenue Market Share by Company in 2021
Figure 27. Europe Digital Companion Diagnostics Revenue Market Share by Type (2017-2028)
Figure 28. Europe Digital Companion Diagnostics Revenue Market Share by Application (2017-2028)
Figure 29. Europe Digital Companion Diagnostics Revenue Share by Country (2017-2028)
Figure 30. Germany Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 31. France Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Digital Companion Diagnostics Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Digital Companion Diagnostics Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Digital Companion Diagnostics Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Digital Companion Diagnostics Revenue Share by Region (2017-2028)
Figure 39. China Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 42. India Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 44. China Taiwan Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Digital Companion Diagnostics Revenue Market Share by Company in 2021
Figure 49. Latin America Digital Companion Diagnostics Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Digital Companion Diagnostics Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Digital Companion Diagnostics Revenue Share by Country (2017-2028)
Figure 52. Mexico Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Digital Companion Diagnostics Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Digital Companion Diagnostics Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Digital Companion Diagnostics Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Digital Companion Diagnostics Revenue Share by Country (2017-2028)
Figure 59. Turkey Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Digital Companion Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 62. Roche Holdings (Switzerland) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 63. Abbott Laboratories (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 64. Thermo Fisher Scientific (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 65. Agilent Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 66. Life Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 67. GE Healthcare (UK) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 68. Agendia (Angola) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 69. Qiagen (Germany) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 70. Genomic Health (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 71. Myriad Genetics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 72. Advanced Cell Diagnostics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 73. Danaher (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 74. Applied Proteomics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs